METHAMPHETAMINE-INDUCED CHANGES IN DEXTROMETHORPHAN AND MIDAZOLAM METABOLISM IN RATS: A PHARMACOKINETIC STUDY

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HADAŠOVÁ Eva DOSTÁLEK Miroslav JUŘICA Jan TOMANDL Josef MINAŘÍKOVÁ Veronika

Year of publication 2004
Type Article in Proceedings
Conference 19th European Workshop on Drug Metabolism. Abstract & Program Book.
MU Faculty or unit

Faculty of Medicine

Citation
Field Pharmacology and pharmaceutical chemistry
Keywords drug metabolism; methamphetamine; dextromethorphan; midazolam; CYP2D6; CYP3A4; pharmacokinetics;
Description Methamphetamine (pervitine) is one of the most frequently abused substances. The drug is metabolized by the hepatic cytochromes P450, mainly by CYP2D and CYP3A. The present pharmacokinetic study in the rat investigated the possible influence of methamphetamine on metabolic fates of model substrates for CYP3A1/2 and CYP2D1/2. The pharmacokinetic analysis showed a marked stimulatory effect of methamphetamine on CYP2D1/2, as it was previously demonstrated by us in the isolated perfused rat liver. Similarly, the midazolam kinetics (marker of CYP3A1/2 activity) showed a significantly increased CYP3A-mediated metabolism. The results may have clinical impact in pharmacotherapy of methamphetamine abusers.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.